Evidence map›Paper›PMID 21935434›Full record

ArticlePloS one2011

Acute drug treatment in the early C. elegans embryo.

Ana Carvalho, Sara K Olson, Edgar Gutierrez, Kelly Zhang, Lisa B Noble, Esther Zanin, Arshad Desai, Alex Groisman, Karen Oegema

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 129 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PLK-1 regulates MEX-1 polarization in thebioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Temporally distinct roles of Aurora A in polarization of thebioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ana CarvalhoLudwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, United States of America.
Sara K Olson
Edgar Gutierrez
Kelly Zhang
Lisa B Noble
Esther Zanin
Arshad Desai
Alex Groisman
Karen Oegema
University of California, San Diego · USLudwig Cancer Research · US

Funding

Analysis of Centrosome DynamicsR01GM074207 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OEGEMA, KAREN F · 2006 to 2025
$6.6M
An Integrative Analysis of MAPK Signaling in Budding YeastR01GM084332 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI LEVCHENKO, ANDRE · 2008 to 2011
$1.2M
NIGMS NIH HHS GM06852NIGMS NIH HHS R01 GM074207NIGMS NIH HHS R01 GM084332
6 · The paper itself

Abstract

Genetic and genome-wide RNAi approaches available in C. elegans, combined with tools for visualizing subcellular events with high-resolution, have led to increasing adoption of the early C. elegans embryo as a model for mechanistic and functional genomic analysis of cellular processes. However, a limitation of this system has been the impermeability of the embryo eggshell, which has prevented the routine use of small molecule inhibitors. Here, we present a method to permeabilize and immobilize embryos for acute inhibitor treatment in conjunction with live imaging. To identify a means to permeabilize the eggshell, we used a dye uptake assay to screen a set of 310 candidate genes defined by a combination of bioinformatic criteria. This screen identified 20 genes whose inhibition resulted in >75% eggshell permeability, and 3 that permeabilized embryos with minimal deleterious effects on embryo production and early embryonic development. To mount permeabilized embryos for acute drug addition in conjunction with live imaging, we combined optimized inhibition of one of these genes with the use of a microfabricated chamber that we designed. We demonstrate that these two developments enable the temporally controlled introduction of inhibitors for mechanistic studies. This method should also open new avenues of investigation by allowing profiling and specificity-testing of inhibitors through comparison with genome-wide phenotypic datasets.

Indexed as

AnimalsBridged Bicyclo Compounds, HeterocyclicCaenorhabditis elegansCaenorhabditis elegans ProteinsEmbryonic DevelopmentLactonesNocodazoleRNA InterferenceThiazolidinesBridged Bicyclo Compounds, HeterocyclicCaenorhabditis elegans ProteinsLactoneslatrunculin ANocodazoleThiazolidines

Identifiers

PMID21935434
PMCPMC3173474
OpenAlexW2012229898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.